Table 2 Thrombocytopenia and its associated factors before HAART initiation in HIV positive patients attending Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2017

 20–29

3(10.7%)

25 (89.3%)

0.3(0.07–1.24)

 30–39

14(24.1%)

44(75.9%)

0.7(0.26–1.97)

0.45

 40–49

18(29.5%)

43(70.5%)

0.9(0.34–2.40)

  ≥ 50

9(31%)

20 (69%)

1

 Female

26(24.3%)

81(75.7%)

0.9(0.47–1.99)

0.93

 Male

18(26.1%)

51(73.9%)

1

 Stage III/IV

27(25.7%)

78(74.3%)

1.1(0.54–2.34)

0.76

 Stage I/II

17(23.9%)

54(76.1%)

1

  < 200

34(28.9%)

88(72.1%)

4.4(0.52–36.28)

0.35

 200–349

9(22.5%)

31(77.5%)

3.3(0.37–29.84)

  ≥ 350

1(7.1%)

13(92.9%)

1